JG
CORV

Jefferies Group’s Correvio Pharma Corp. Ordinary Shares (Canada) CORV Stock Holding History

Jefferies Group’s Portfolio CORV Stock Details CORV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-10,000
Closed -$21K – 2946
2017
Q3 		$21K Buy
+10,000
New +$34K ﹤0.01% 2250

Other funds holding CORV

Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
SCM
Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return
PI
Putnam Investments Boston, Massachusetts $75.7B AUM 34.45% 1-Year Est. Return
CCP
Clough Capital Partners Boston, Massachusetts $1.23B AUM 51.32% 1-Year Est. Return
TA
Tamarack Advisers Carlsbad, California $2.12M AUM 58.09% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $2.05B AUM 161.37% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
DMK
David M. Knott $275M AUM 59.23% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return

Jefferies Group's CORV Position: Q4 2017 in Review

Jefferies Group sold out of Correvio Pharma Corp. Ordinary Shares (Canada) (CORV) in Q4 2017, closing a stake of 10,000 shares — an estimated $21K sold.

Jefferies Group first reported a position in CORV in Q3 2017 and held it in 1 quarter. The position peaked at $21K in Q3 2017. 27 funds tracked by Wall St. Rank hold CORV as of Q4 2017.

  • Jefferies Group reported no remaining Correvio Pharma Corp. Ordinary Shares (Canada) position as of Q4 2017 after selling out during the quarter.
  • Jefferies Group sold 10,000 Correvio Pharma Corp. Ordinary Shares (Canada) shares in Q4 2017, an estimated $21K.
  • Jefferies Group first reported a position in Correvio Pharma Corp. Ordinary Shares (Canada) in Q3 2017 and held it in 1 quarter.
  • Jefferies Group's Correvio Pharma Corp. Ordinary Shares (Canada) position peaked at $21K in Q3 2017.
  • 27 funds tracked by Wall St. Rank held Correvio Pharma Corp. Ordinary Shares (Canada) as of Q4 2017.

Based on Jefferies Group's 13F filing for Q4 2017, filed 14 Feb 2018.